A.J. Littlewood

688 total citations
8 papers, 587 citations indexed

About

A.J. Littlewood is a scholar working on Molecular Biology, Oncology and Rheumatology. According to data from OpenAlex, A.J. Littlewood has authored 8 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Rheumatology. Recurrent topics in A.J. Littlewood's work include Bone Metabolism and Diseases (6 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Immune Response and Inflammation (2 papers). A.J. Littlewood is often cited by papers focused on Bone Metabolism and Diseases (6 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Immune Response and Inflammation (2 papers). A.J. Littlewood collaborates with scholars based in United Kingdom, Netherlands and Switzerland. A.J. Littlewood's co-authors include Maxine Gowen, Robert A. Dodds, R.G.G. Russell, Dean B. Evans, D. E. Hughes, Jean E. Russell, Karen Chapman, David Hughes, L Aarden and Terence O’Reilly and has published in prestigious journals such as Clinical Cancer Research, Journal of Cell Science and Endocrinology.

In The Last Decade

A.J. Littlewood

8 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.J. Littlewood United Kingdom 6 367 215 147 77 70 8 587
Séverine Couillaud France 10 414 1.1× 376 1.7× 107 0.7× 58 0.8× 89 1.3× 12 682
Linda Rothe United States 9 517 1.4× 326 1.5× 114 0.8× 138 1.8× 89 1.3× 10 790
Shuzo Tagashira Japan 7 507 1.4× 162 0.8× 110 0.7× 54 0.7× 66 0.9× 8 662
Diane Horn United States 11 430 1.2× 240 1.1× 85 0.6× 170 2.2× 66 0.9× 16 719
Valerie A. Siclari United States 9 341 0.9× 281 1.3× 102 0.7× 42 0.5× 120 1.7× 10 658
Konosuke Nakayama Japan 9 337 0.9× 204 0.9× 97 0.7× 45 0.6× 33 0.5× 13 625
Manali Bendre United States 7 551 1.5× 578 2.7× 99 0.7× 121 1.6× 126 1.8× 8 990
Kazuki Yano Japan 3 499 1.4× 409 1.9× 97 0.7× 55 0.7× 126 1.8× 4 627
Bénédicte Brounais France 7 347 0.9× 223 1.0× 84 0.6× 182 2.4× 47 0.7× 11 714
Madoka Hayashi Japan 4 378 1.0× 210 1.0× 87 0.6× 52 0.7× 91 1.3× 7 507

Countries citing papers authored by A.J. Littlewood

Since Specialization
Citations

This map shows the geographic impact of A.J. Littlewood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.J. Littlewood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.J. Littlewood more than expected).

Fields of papers citing papers by A.J. Littlewood

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.J. Littlewood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.J. Littlewood. The network helps show where A.J. Littlewood may publish in the future.

Co-authorship network of co-authors of A.J. Littlewood

This figure shows the co-authorship network connecting the top 25 collaborators of A.J. Littlewood. A scholar is included among the top collaborators of A.J. Littlewood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.J. Littlewood. A.J. Littlewood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Wyder, Lorenza, Christian Schnell, Terence O’Reilly, et al.. (2005). The Antitumor and Antiangiogenic Activity of Vascular Endothelial Growth Factor Receptor Inhibition Is Potentiated by ErbB1 Blockade. Clinical Cancer Research. 11(12). 4521–4532. 67 indexed citations
2.
Dodds, Robert A., et al.. (1994). Expression of mRNA for IL1 beta, IL6 and TGF beta 1 in developing human bone and cartilage.. Journal of Histochemistry & Cytochemistry. 42(6). 733–744. 95 indexed citations
3.
Dodds, Robert A., et al.. (1993). A method for the localization of cytokine mRNA expression in adult human bone by in situ hybridization. Bone. 14(3). 305–307. 5 indexed citations
4.
Dodds, Robert A., et al.. (1993). Expression of osteopontin mRNA by osteoclasts and osteoblasts in modelling adult human bone. Journal of Cell Science. 104(4). 1013–1020. 128 indexed citations
5.
Littlewood, A.J., et al.. (1992). 1. Modulation of the expression of IL-6 and its receptor mRNA in human osteoblasts in vitro. Bone. 13(3). 273–273. 1 indexed citations
6.
Littlewood, A.J., L Aarden, Dean B. Evans, R.G.G. Russell, & Maxine Gowen. (1991). Human osteoblastlike cells do not respond to interleukin-6. Journal of Bone and Mineral Research. 6(2). 141–148. 57 indexed citations
7.
Littlewood, A.J., et al.. (1991). The Modulation of the Expression of IL-6 and Its Receptor in Human Osteoblastsin Vitro*. Endocrinology. 129(3). 1513–1520. 141 indexed citations
8.
Gowen, Maxine, Karen Chapman, A.J. Littlewood, et al.. (1990). Production of Tumor Necrosis Factor by Human Osteoblasts is Modulated by Other Cytokines, but not by Osteotropic Hormones*. Endocrinology. 126(2). 1250–1255. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026